Neil Kumar - Aug 11, 2025 Form 3 Insider Report for BridgeBio Oncology Therapeutics, Inc. (BBOT)

Role
Director
Signature
/s/ Aaron Chan, Attorney-in-Fact
Stock symbol
BBOT
Transactions as of
Aug 11, 2025
Transactions value $
$0
Form type
3
Date filed
8/18/2025, 05:13 PM
Previous filing
Aug 11, 2025
Next filing
Aug 19, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kumar Neil Director BRIDGEBIO ONCOLOGY THERAPEUTICS, INC., 256 EAST GRAND AVENUE, SUITE 104, SOUTH SAN FRANCISCO /s/ Aaron Chan, Attorney-in-Fact 2025-08-18 0001742485

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney